| Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection JF Fahrmann, CM Schmidt, X Mao, E Irajizad, M Loftus, J Zhang, N Patel, ... Gastroenterology 160 (4), 1373-1383. e6, 2021 | 105 | 2021 |
| Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer J Vykoukal, JF Fahrmann, JR Gregg, Z Tang, S Basourakos, E Irajizad, ... Nature communications 11 (1), 4279, 2020 | 64 | 2020 |
| Blood-based biomarker panel for personalized lung cancer risk assessment JF Fahrmann, T Marsh, E Irajizad, N Patel, E Murage, J Vykoukal, ... Journal of Clinical Oncology 40 (8), 876, 2022 | 48 | 2022 |
| Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple-negative breast cancer JF Fahrmann, J Vykoukal, A Fleury, S Tripathi, JB Dennison, E Murage, ... JNCI: Journal of the National Cancer Institute 112 (6), 607-616, 2020 | 47 | 2020 |
| Protein citrullination as a source of cancer neoantigens H Katayama, M Kobayashi, E Irajizad, AM Sevillano, N Patel, X Mao, ... Journal for immunotherapy of cancer 9 (6), 2021 | 32 | 2021 |
| Mutational activation of the NRF2 pathway upregulates kynureninase resulting in tumor immunosuppression and poor outcome in lung adenocarcinoma JF Fahrmann, I Tanaka, E Irajizad, X Mao, JB Dennison, E Murage, ... Cancers 14 (10), 2543, 2022 | 20 | 2022 |
| Plasma-derived extracellular vesicles convey protein signatures that reflect pathophysiology in lung and pancreatic adenocarcinomas JF Fahrmann, X Mao, E Irajizad, H Katayama, M Capello, I Tanaka, T Kato, ... Cancers 12 (5), 1147, 2020 | 18 | 2020 |
| Clathrin polymerization exhibits high mechano-geometric sensitivity E Irajizad, N Walani, SL Veatch, AP Liu, A Agrawal Soft Matter 13 (7), 1455-1462, 2017 | 17 | 2017 |
| A MYC-driven plasma polyamine signature for early detection of ovarian cancer JF Fahrmann, E Irajizad, M Kobayashi, J Vykoukal, JB Dennison, ... Cancers 13 (4), 913, 2021 | 16 | 2021 |
| CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop Y Chen, M Capello, MVR Perez, JV Vykoukal, D Roife, Y Kang, ... Molecular metabolism 56, 101426, 2022 | 14 | 2022 |
| CES2 Expression in pancreatic adenocarcinoma is predictive of response to irinotecan and is associated with type 2 diabetes M Capello, JF Fahrmann, MV Rios Perez, JV Vykoukal, E Irajizad, ... JCO Precision Oncology 4, 426-436, 2020 | 14 | 2020 |
| Geometric instability catalyzes mitochondrial fission E Irajizad, R Ramachandran, A Agrawal Molecular biology of the cell 30 (1), 160-168, 2019 | 14 | 2019 |
| A blood-based polyamine signature associated with MEN1 duodenopancreatic neuroendocrine tumor progression JF Fahrmann, AR Wasylishen, CRC Pieterman, E Irajizad, J Vykoukal, ... The Journal of Clinical Endocrinology & Metabolism 106 (12), e4969-e4980, 2021 | 10 | 2021 |
| Proteome profiling uncovers an autoimmune response signature that reflects ovarian cancer pathogenesis M Kobayashi, H Katayama, E Irajizad, JV Vykoukal, JF Fahrmann, ... Cancers 12 (2), 485, 2020 | 10 | 2020 |
| A blood-based metabolomic signature predictive of risk for pancreatic cancer E Irajizad, A Kenney, T Tang, J Vykoukal, R Wu, E Murage, JB Dennison, ... Cell Reports Medicine 4 (9), 2023 | 9 | 2023 |
| Application of artificial intelligence to plasma metabolomics profiles to predict response to neoadjuvant chemotherapy in triple-negative breast cancer E Irajizad, R Wu, J Vykoukal, E Murage, R Spencer, JB Dennison, ... Frontiers in Artificial Intelligence 5, 876100, 2022 | 7 | 2022 |
| Vesicle adhesion reveals novel universal relationships for biophysical characterization E Irajizad, A Agrawal Biomechanics and modeling in mechanobiology 17, 103-109, 2018 | 7 | 2018 |
| Mortality benefit of a blood-based biomarker panel for lung cancer on the basis of the prostate, lung, colorectal, and ovarian cohort E Irajizad, JF Fahrmann, T Marsh, J Vykoukal, JB Dennison, JP Long, ... Journal of Clinical Oncology 41 (27), 4360-4368, 2023 | 6 | 2023 |
| Kynureninase upregulation is a prominent feature of NFR2-activated cancers and is associated with tumor immunosuppression and poor prognosis RA León-Letelier, AH Abdel Sater, Y Chen, S Park, R Wu, E Irajizad, ... Cancers 15 (3), 834, 2023 | 6 | 2023 |
| A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses E Irajizad, CY Han, J Celestino, R Wu, E Murage, R Spencer, ... Clinical Cancer Research 28 (21), 4669-4676, 2022 | 5 | 2022 |
Jennifer DennisonUniversity of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
